INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 200 | -50.0% | 0.00% | – |
| Q4 2022 | $0 | – | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 400 | -63.6% | 0.00% | – |
| Q2 2022 | $1,000 | -92.9% | 1,100 | -91.1% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | -33.3% | 12,382 | +20.4% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | +2000.0% | 10,282 | -12.9% | 0.00% | – |
| Q3 2021 | $1,000 | – | 11,800 | +11700.0% | 0.00% | – |
| Q4 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | -80.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 500 | -72.2% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,800 | +260.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 500 | -95.5% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | – | 11,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |